HRP20070081T5 - Nasal pharmaceutical composition of piribedil - Google Patents
Nasal pharmaceutical composition of piribedilInfo
- Publication number
- HRP20070081T5 HRP20070081T5 HR20070081T HRP20070081T HRP20070081T5 HR P20070081 T5 HRP20070081 T5 HR P20070081T5 HR 20070081 T HR20070081 T HR 20070081T HR P20070081 T HRP20070081 T HR P20070081T HR P20070081 T5 HRP20070081 T5 HR P20070081T5
- Authority
- HR
- Croatia
- Prior art keywords
- piribedil
- pharmaceutical composition
- nasal pharmaceutical
- pharmaceutically acceptable
- nasal
- Prior art date
Links
- 229960004310 piribedil Drugs 0.000 title abstract 3
- OQDPVLVUJFGPGQ-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]pyrimidine Chemical group C=1C=C2OCOC2=CC=1CN(CC1)CCN1C1=NC=CC=N1 OQDPVLVUJFGPGQ-UHFFFAOYSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229920000858 Cyclodextrin Polymers 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0308712A FR2857594B1 (fr) | 2003-07-17 | 2003-07-17 | Composition pharmaceutique pour l'administration par voie nasale de piribedil |
PCT/FR2004/001867 WO2005009442A1 (fr) | 2003-07-17 | 2004-07-16 | Composition pharmaceutique pour l’administration par voie nasale de piribedil |
Publications (2)
Publication Number | Publication Date |
---|---|
HRP20070081T3 HRP20070081T3 (en) | 2007-04-30 |
HRP20070081T5 true HRP20070081T5 (en) | 2007-08-31 |
Family
ID=33548200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20070081T HRP20070081T5 (en) | 2003-07-17 | 2007-02-28 | Nasal pharmaceutical composition of piribedil |
Country Status (30)
Country | Link |
---|---|
US (1) | US20060204449A1 (xx) |
EP (1) | EP1653963B1 (xx) |
JP (1) | JP2007516947A (xx) |
KR (1) | KR100807480B1 (xx) |
CN (1) | CN100540004C (xx) |
AR (1) | AR046808A1 (xx) |
AT (1) | ATE349213T1 (xx) |
AU (1) | AU2004258714A1 (xx) |
BR (1) | BRPI0412681A (xx) |
CA (1) | CA2532631C (xx) |
CY (1) | CY1106013T1 (xx) |
DE (1) | DE602004003955T2 (xx) |
DK (1) | DK1653963T3 (xx) |
EA (1) | EA011041B1 (xx) |
ES (1) | ES2279435T3 (xx) |
FR (1) | FR2857594B1 (xx) |
GE (1) | GEP20074259B (xx) |
HK (1) | HK1094153A1 (xx) |
HR (1) | HRP20070081T5 (xx) |
MA (1) | MA27864A1 (xx) |
MX (1) | MXPA06000641A (xx) |
MY (1) | MY137747A (xx) |
NO (1) | NO332776B1 (xx) |
NZ (1) | NZ544460A (xx) |
PL (1) | PL1653963T3 (xx) |
PT (1) | PT1653963E (xx) |
SI (1) | SI1653963T1 (xx) |
UA (1) | UA85193C2 (xx) |
WO (1) | WO2005009442A1 (xx) |
ZA (1) | ZA200600240B (xx) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8969417B2 (en) | 2008-06-06 | 2015-03-03 | Pharmatwob Ltd. | Pharmaceutical compositions for treatment of Parkinsons disease |
CN105163729A (zh) * | 2013-03-13 | 2015-12-16 | N到B有限公司 | 用于治疗与帕金森氏病相关的运动和抑郁症状的方法、组合物和装置 |
IT201800005117A1 (it) * | 2018-05-07 | 2019-11-07 | Acqua irradiata con energie elettromagnetiche per uso terapeutico |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE1007402A5 (nl) * | 1993-03-26 | 1995-06-06 | Adir | Nasale farmaceutische preparaten met progestagene stof. |
ES2239369T3 (es) * | 1993-03-26 | 2005-09-16 | Franciscus Wilhelmus Henricus Maria Merkus | Composiciones farmaceuticas para administracion intranasal de dihidroergotamina. |
FR2710268B1 (fr) * | 1993-09-22 | 1995-10-20 | Adir | Utilisation de beta-cyclodextrines partiellement méthylées comme promoteurs d'absorption dans la préparation de compositions pharmaceutiques pour l'administration transcutanée de principes actifs. |
FR2710265B1 (fr) * | 1993-09-22 | 1995-10-20 | Adir | Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs. |
FR2742989B1 (fr) * | 1995-12-29 | 1998-01-23 | Adir | Composition pharmaceutique bioadhesive pour la liberation controlee de principes actifs |
NZ501321A (en) * | 1997-03-26 | 2001-04-27 | Franciscus W | Nasal Melatonin composition |
EP0900567A3 (en) * | 1997-09-05 | 2001-05-02 | Pfizer Products Inc. | Quinazoline-4-one AMPA antagonists for the treatment of dyskinesias associated with dopamine agonist therapy |
US20020002175A1 (en) * | 2000-09-19 | 2002-01-03 | Charanjit Behl | Nasal delivery of apomorphine in combination with glycol derivatives |
US20040028613A1 (en) * | 2001-06-25 | 2004-02-12 | Nastech Pharmaceutical Company Inc | Dopamine agonist formulations for enhanced central nervous system delivery |
FR2827516B1 (fr) * | 2001-07-19 | 2003-09-19 | Servier Lab | Composition pharmaceutique pour l'administration par voie nasale d'estradiol et de norethisterone |
-
2003
- 2003-07-17 FR FR0308712A patent/FR2857594B1/fr not_active Expired - Fee Related
-
2004
- 2004-07-15 MY MYPI20042838A patent/MY137747A/en unknown
- 2004-07-15 AR ARP040102489A patent/AR046808A1/es unknown
- 2004-07-16 SI SI200430163T patent/SI1653963T1/sl unknown
- 2004-07-16 ZA ZA200600240A patent/ZA200600240B/en unknown
- 2004-07-16 CA CA2532631A patent/CA2532631C/fr not_active Expired - Fee Related
- 2004-07-16 DE DE602004003955T patent/DE602004003955T2/de active Active
- 2004-07-16 US US10/564,139 patent/US20060204449A1/en not_active Abandoned
- 2004-07-16 AT AT04767691T patent/ATE349213T1/de active
- 2004-07-16 PL PL04767691T patent/PL1653963T3/pl unknown
- 2004-07-16 EP EP04767691A patent/EP1653963B1/fr active Active
- 2004-07-16 BR BRPI0412681-5A patent/BRPI0412681A/pt not_active IP Right Cessation
- 2004-07-16 MX MXPA06000641A patent/MXPA06000641A/es active IP Right Grant
- 2004-07-16 ES ES04767691T patent/ES2279435T3/es active Active
- 2004-07-16 AU AU2004258714A patent/AU2004258714A1/en not_active Abandoned
- 2004-07-16 KR KR1020067001141A patent/KR100807480B1/ko not_active IP Right Cessation
- 2004-07-16 NZ NZ544460A patent/NZ544460A/en not_active IP Right Cessation
- 2004-07-16 DK DK04767691T patent/DK1653963T3/da active
- 2004-07-16 CN CNB2004800197495A patent/CN100540004C/zh not_active Expired - Fee Related
- 2004-07-16 JP JP2006519966A patent/JP2007516947A/ja active Pending
- 2004-07-16 EA EA200600172A patent/EA011041B1/ru not_active IP Right Cessation
- 2004-07-16 WO PCT/FR2004/001867 patent/WO2005009442A1/fr active IP Right Grant
- 2004-07-16 PT PT04767691T patent/PT1653963E/pt unknown
- 2004-07-16 UA UAA200601630A patent/UA85193C2/ru unknown
- 2004-07-16 GE GEAP20049239A patent/GEP20074259B/en unknown
-
2005
- 2005-12-27 MA MA28688A patent/MA27864A1/fr unknown
-
2006
- 2006-02-16 NO NO20060743A patent/NO332776B1/no not_active IP Right Cessation
-
2007
- 2007-01-24 HK HK07100838.9A patent/HK1094153A1/xx not_active IP Right Cessation
- 2007-02-13 CY CY20071100190T patent/CY1106013T1/el unknown
- 2007-02-28 HR HR20070081T patent/HRP20070081T5/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20060240T3 (en) | Intranasal formulation of rotigotine | |
CY1105120T1 (el) | Η αντιμετωπιση αναπνευστικων νοσων | |
HRP20041152B1 (en) | Pharmaceutical formulations | |
RS50876B (sr) | Upotreba flibanserina u lečenju seksualnih poremećaja | |
RS52831B (en) | THIN BUPRENORPHINE TILES FOR DRUG REPLACEMENT THERAPY | |
ATE513541T1 (de) | Pharmazeutische zusammensetzungen zur oralen verabreichung von calcitonin | |
RS52367B (en) | GLATIRAMER ACETATE FORMULATION FORMATED VOLUMES AND APPLICATION PROCEDURES | |
CR7362A (es) | Formulaciones farmaceuticas de derivado de platino | |
EA200702522A1 (ru) | Система доставки лекарств в полость рта и способы ее применения | |
CY1110906T1 (el) | Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης | |
CY1108676T1 (el) | Οφθαλμικο εναιωρημα περιλαμβανον ενα οφθαλμικο φαρμακο, μια πολοξαμινη και εναν παραγοντα ρυθμισεως της τονικοτητας τυπου γλυκολης, χρηση της εν λογω συνθεσεως για την παραγωγη ενος φαρμακου για την αγωγη οφθαλμικων διαταραχων | |
RS52315B (en) | DIARYLMETHYL PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE | |
ATE499939T1 (de) | Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend | |
DK1104289T3 (da) | Hidtil ukendte orale formuleringer for 5-HT4-agonister eller -antagonister | |
HRP20070291T3 (en) | Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis | |
DE60102590D1 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
DE602004023093D1 (de) | N mit einem abgabemittel in mikronisierter form | |
EA200600603A1 (ru) | Оральная система доставки лекарственного препарата | |
BRPI0417350A2 (pt) | composiÇço para a distribuiÇço nasal, uso de granisetron ou de um sal farmaceuticamente aceitÁvel do mesmo, e quitosana, um sal, um derivado ou sal de um derivado do mesmo, mÉtodos de administraÇço de granisetron ou de um sal farmaceuticamente aceitÁvel do mesmo, e de tratamento ou prevenÇço de nÁusea e/ou vâmito, e, dispositivo para a distribuiÇço da droga nasal ou um cartucho de dose | |
HRP20070081T5 (en) | Nasal pharmaceutical composition of piribedil | |
SE0001916D0 (sv) | Novel formulation | |
BR0206960A (pt) | Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose | |
ATE297760T1 (de) | Pharmazeutische zusammensetzungen enthaltend terbinafin | |
FR2793685B1 (fr) | Compositions pharmaceutiques, destinees a l'administration par voie orale de phloroglucinol et leur preparation | |
YU87501A (sh) | Farmaceutski kompleksi |